Get the StoQuant digest — free

Free StoQuant digest by email. No account needed. See today's research picks.

Subscribe free

AZN vs PFE — Stock Comparison

Compare AZN and PFE side-by-side on StoQuant: AZN Q-Score 43 vs PFE 65; analyst signal 61 vs 60. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.

Side-by-side snapshot

• AZN — AstraZeneca PLC · Health Care · market cap $263.77B · Q-Score verdict Hold (43.0, grade C) · analyst signal 61/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 39/100, technicals 38/100 · weakest signals: ML forecast 7/100. Full AZN research.
• PFE — PFIZER INC · Health Care · market cap $169.85B · Q-Score verdict Buy (65.0, grade B) · analyst signal 60/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: technicals 97/100, competitive moat 52/100 · weakest signals: earnings quality 14/100, social sentiment 11/100. Full PFE research.

What you can compare

• Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
• Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
• Insider activity: Cluster scores and recent Form 4 buying.
• Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
• Strategic edges: Competitive moat and durable advantage analysis.
• Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
• Macro context: Market regime and sector rotation alignment.

Deep dive: AZN research · PFE research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →